- Home
- PHAR vs HBNC Comparison
PHAR vs HBNC Comparison
Compare PHAR & HBNC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PHAR | HBNC |
|---|---|---|
| Founded | 1988 | 1873 |
| Country | Netherlands | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 883.5M |
| IPO Year | 2020 | 1995 |
Fundamental Metrics
Financial Performance| Metric | PHAR | HBNC |
|---|---|---|
| Price | $16.60 | $16.94 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 2 | 4 |
| Target Price | ★ $39.00 | $20.25 |
| AVG Volume (30 Days) | 17.7K | ★ 289.1K |
| Earning Date | 05-07-2026 | 04-22-2026 |
| Dividend Yield | N/A | ★ 3.79% |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $10.04 | N/A |
| Revenue Next Year | $2.51 | $4.99 |
| P/E Ratio | $3,041.22 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $7.79 | $12.71 |
| 52 Week High | $21.34 | $19.07 |
Technical Indicators
Market Signals| Indicator | PHAR | HBNC |
|---|---|---|
| Relative Strength Index (RSI) | 55.12 | 57.85 |
| Support Level | $16.55 | $15.61 |
| Resistance Level | $17.60 | $17.03 |
| Average True Range (ATR) | 0.61 | 0.41 |
| MACD | 0.15 | 0.15 |
| Stochastic Oscillator | 81.86 | 96.13 |
Price Performance
Historical ComparisonAbout PHAR Pharming Group N.V.
Pharming Group is a biopharmaceutical company focused in transforming the lives of patients with rare, debilitating, and life-threatening diseases. The company is actively developing and commercializing a diverse portfolio of innovative treatments, including both biologics and small molecule therapies. Its commercial products are RUCONEST, approved for the treatment of acute attacks in adult and adolescent patients with hereditary angioedema, or HAE; and Joenja (leniolisib), a small-molecule kinase inhibitor, developed for the treatment of activated phosphoinositide 3-kinase delta syndrome.
About HBNC Horizon Bancorp Inc.
Horizon Bancorp (IN) is a United States-based holding company providing banking services. It is engaged in providing commercial and retail banking services, corporate and individual trust and agency services, and other services incident to banking. The company also provides commercial loans, real estate loans, mortgage warehouse loans, consumer loans, and other credit facilities. The company has one principal business segment, commercial banking.